Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection

NCT00734344 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute HIV Infection

Interventions

DRUG: Raltegravir
DRUG: Efavirenz
DRUG: Emtricitibine
DRUG: Tenofovir disoproxil once daily
DRUG: Tenofovir disoproxil twice daily

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]